FURENTANG FUREN Metronidazole Clotrimazole And Chlorhexidine Acetate Effervescent Tablets For Female Genital Inflammation 7 Tablets

(No reviews yet) Write a Review
$15.99
Origin:
China
Manufacturer:
FURENTANG
Form:
Tablets
Specification:
7 Tablets
Storage Life:
24 months
Adding to cart… The item has been added

Product Overview

[Drug name]
Generic name: Shuangzuotai vaginal effervescent tablets
Trade name: Furen
English name: Metronidazole, Clotrimazole and Chlorhexidine Acetate Effervescent Tablets
Chinese Pinyin: Shuangzuotai Yindao Paoteng Pian
[Ingredients]
This product is a compound preparation, each tablet contains the main ingredients of metronidazole 0.2g, clotrimazole 0.16g, chlorhexidine acetate 0.008g. Excipients are: anhydrous citric acid, sodium bicarbonate, dextrin, magnesium stearate, povidone
[Properties]
This product is a white or off-white tablet with slight scars on the surface
[Indications]
For bacterial vaginosis, candidal vulvovaginal disease, trichomoniasis vaginitis and mixed bacterial, fungal, and trichomoniasis vaginitis
[Usage and Dosage]
Vaginal administration. Place this product in the posterior fornix of the vagina, 1 tablet at a time, once a day. Continuous use for 7 days is a course of treatment, and a course of treatment is repeated after the first menstrual period after discontinuation of the drug.
[Adverse Reactions]
Occasionally, rash, vaginal burning sensation, itching or other mucosal irritation symptoms may occur. Because this product can be absorbed from the mucosa, long-term and large-scale use may also produce the same adverse reactions as systemic medication, such as nausea, lack of appetite, vomiting, diarrhea, abdominal discomfort, taste changes, dry mouth, metallic taste in the mouth, etc. Epileptic seizures and peripheral neuropathy, the latter mainly manifested as numbness and paresthesia of the extremities. Others have reversible granulocytopenia. Allergic reactions such as rash, urticaria, itching, etc. Central nervous system symptoms such as headache, dizziness, syncope, paresthesia, limb numbness, ataxia and mental confusion. Elevated serum aminotransferase, fever, cystitis, dysuria, dark urine, etc. are all reversible and can recover on their own after discontinuation of the drug.
[Contraindications]
1. Patients allergic to pyrrole (imidazole) drugs are contraindicated. 2. Patients with active central nervous system diseases and blood diseases are contraindicated. 3. Pregnant women are prohibited from using this product.
[Precautions]
1. This product is only for vaginal administration, and should not be taken orally. 2. Avoid using this product during menstruation. 3. Women with no sexual history should use this product under the guidance of a physician. 4. Wash your hands or wear cots or gloves when administering this product. 5. If there is a burning sensation, redness, swelling, etc. at the medication site, stop taking the drug, wash the local drug, and consult a physician if necessary. 6. Pay attention to personal hygiene during medication, prevent repeated infection, use condoms or avoid sexual intercourse. 7. Lactating women should stop breastfeeding when using this product. 8. Elderly people should use this product with caution. 9. If allergic symptoms or adverse reactions of the central nervous system occur during use, stop taking the drug immediately. 10. Use with caution in patients with liver and kidney dysfunction. 11. When treating vaginal trichomoniasis, their sexual partners must be treated at the same time. 12. Do not drink alcohol or beverages containing alcohol while taking this product. 13. It is forbidden for those who are allergic to this product, and it should be used with caution by those with allergic constitution. 14. It is forbidden to use this product when its properties change. 15. Please keep this product out of reach of children. 16. If you are using other medicines, please consult a doctor or pharmacist before using this product.
[Special population medication]
Children's precautions: Not recommended. Because children are in the reproductive system development period.
Precautions during pregnancy and lactation: Prevented for pregnant women.
Elderly precautions: Due to decreased liver function, the elderly have changes in drug metabolism when using this product, so it should be used with caution.
[Drug interactions]
1. Chlorhexidine is incompatible with soap, potassium iodide, etc. It is also incompatible with borax, bicarbonate, carbonate, oxide, citrate, phosphate and sulfate. 2. When this product is used in combination with oxytetracycline, the latter can interfere with the effect of metronidazole in removing vaginal Trichomonas. 3. After long-term and large-scale use, it can also produce drug interactions similar to systemic medication after absorption through the mucosa, such as inhibiting the metabolism of warfarin and other oral anticoagulants, interfering with disulfiram metabolism and serum aminotransferase and lactate dehydrogenase test results, and combining with liver microsomal enzyme inducers or inhibitors to accelerate or slow down the metabolism of this product in the liver. 4. If used with other drugs at the same time, drug interactions may occur. Please consult a physician or pharmacist for details.
[Pharmacological Action]
The metronidazole contained in this product is an azole anti-anaerobic and anti-trichomonal drug; clotrimazole is a broad-spectrum antifungal drug that has antibacterial effects on a variety of superficial and deep fungi. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes; chlorhexidine acetate is a quaternary ammonium salt cationic surfactant that has a bactericidal effect on Gram-positive bacteria. The combination of the three drugs has a synergistic effect, which is not only suitable for simple fungal, bacterial or trichomonal infections, but also for mixed infections.
[Storage] Keep away from light, sealed, and stored in a dry place
[Specification] Each tablet of this product contains 0.2g of metronidazole, 0.16g of clotrimazole, and 0.008g of chlorhexidine acetate
[Packaging specifications] Composite film for drug packaging (PET/AL/PE)
[Validity period] 24 months
[Implementation standard] State Food and Drug Administration New Drug Standard Volume 22 WS1-(X-091)-2000Z
[Approval number] National Medicine Standard H20057199
[Instruction manual revision date] July 7, 2013
[Manufacturer] Company name: Henan Fu Ren Tang Pharmaceutical Co., Ltd.

Reviews

(No reviews yet) Write a Review